Anmeldung erfolgt in Kürze...
Details werden geladen...
Tukaram Mundhe cracks down: Maharashtra FDA cancels licence of Cipla's Pune unit over regulatory violations, Cipla contests action - The Economic Times
Maharashtra FDA cancelled Cipla's Pune C&F unit drug sale licenses due to serious storage and recall issues. Inspectors found unauthorized claims on Reactin Plus Tablets packaging and seized stock valued at over eleven lakh rupees. The company failed to fully comply with market recall directions and address further distribution system discrepancies. Cipla Pharma & Life Sciences is contesting the order, stating the matter is currently sub judice.
Ähnliche Seiten
Tukaram Mundhe-led Maharashtra FDA cancels Cipla unit's drug licence over Reactin Plus irregularities | Today News
https://www.livemint.com/news/india/tukaram-mundhe-led-maharashtra-fda-cancels-cipla-units-drug-licence-over-reactin-plus-irregularities-11787921799707.html
FDA cancels Cipla Pune unit's licence over Reactin Plus violations; firm contests - India Today
https://www.indiatoday.in/business/story/fda-cancels-cipla-pune-units-drug-licence-over-reactin-plus-storage-record-keeping-lapses-2982065-2026-08-28
Maharashtra FDA Cancels Drug Sale Licences Of Cipla Pharma & Life Sciences’ Pune C&F Unit Over Reactin Plus Irregularities
https://www.freepressjournal.in/business/maharashtra-fda-cancels-drug-sale-licences-of-cipla-pharma-life-sciences-pune-cf-unit-over-reactin-plus-irregularities
Maharashtra FDA crackdown on Cipla Pharma's Pune unit, cancels licence over 'unauthorised promotional text' on Reactin Plus
https://www.dnaindia.com/india/report-maharashtra-fda-crackdown-on-cipla-pharma-s-pune-unit-cancels-licence-over-unauthorised-promotional-text-on-reactin-plus-3219424
Maharashtra FDA strikes again, brings the axe down on Cipla's drug sale licences over irregularities
https://www.india.com/news/india/maharashtra-fda-cancels-cipla-pharma-pune-unit-drug-sale-licences-over-irregularities-reactin-plus-recall-storage-lapses-tukaram-mundhe-8512037/